
Sign up to save your podcasts
Or


Jean Hebert is a professor of neurogenetics at Albert Einstein College of Medicine and the author of the book "Replacing Aging". We discuss his ambitious program to reverse aging in the brain by progressive replacement of neural tissue.
Keshav Singh (University of Alabama) and Greg Schmergel (Nantero) are the co-founders of Yuva Biosciences, an early-stage biotech company developing drugs and natural compounds to reverse aging by targeting mitochondria.
Marc Bernegger and Tobias Reichmuth are co-founders of Maximon, a longevity venture building company based in Switzerland. Collin Ewald is a professor at ETH Zurich, a world expert on extracellular matrix, and a scientific advisor at Maximon.
Daniel Ives is the founder and CEO of Shift Bioscience, an early-stage longevity biotechnology company developing anti-aging drugs based on mitochondrial pathways and a single-cell epigenetics discovery platform.
From the publisher's feed